CT Bone Mineral Analysis (BMA)

Track degenerative and metabolic bone disease

CT Bone Mineral Analysis (BMA) is designed to measure bone density in one or multiple time points. Using an internal reference method*, the application reduces reproducibility errors in multiple time point measurements and provides T- and Z- scores which help physicians assess the risk of osteoporosis.

bone mineral analysis thumbnail

Benefits

  • The user can compare a patient’s results to several reference populations.

*Muller DK, et al., Phantom-less QCT BMD system as screening tool for osteoporosis without additional radiation. Eur J Radiol. 2011; 79(3):375–81.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.

Continue Cancel